MEPHARMA
ActiveSummary
MEPHARMA has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €453,300 and a net result of €60,000. Equity is growing by ~25.7% per year across the filed fiscal years. Its solvency ranks better than 77% of 10645 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
What they do
Retail sale of pharmaceutical products
NACE 47730
1 site
How big
€701,341total assets 2025
- Staff
- 1.2 FTE
- Equity
- €453,300
- Profit
- €60,000
Turnover not published (abridged schema)
Who decides
Accounts filed 56 d late0 of 3 deeds read
Why 85- Higher-failure-rate sector+ Annual accounts: healthy financial profile+ Long track recordFiled after the deadlineShow the evidence
Checked score
Score 2025
Axes · tick = 2024
Profitability79▼-2
Solvency90▲+8
Growth78=
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35,000 at 30 days acceptable
Liquidity ample (current ratio 11.64 against 9.04 in 2024; short-term debt: 8.3% and cash: 34.1% of total assets), and 35.4% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
64.6%
Return on assets
8.6%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 25-09-2026, 56 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
56 d late
2024
12 d late
2023
48 d late
2022
107 d late
2021
117 d late
2020
142 d late
2019
114 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 85 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 25 September (4 of the last 5 filed years within 51 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
- Annual accounts filedfiscal year 2025 · abbreviated…
- Annual accounts filedfiscal year 2024 · abbreviated…
- Annual accounts filedfiscal year 2023 · abbreviated…
Financials
Fiscal year 2025Total assets €701,341Profit €60,000Solvency 64.6%Liquidity 11.64
Total assets
€701,341▲ 2.5%
2018 - 2025
Net result
€60,000▼ 7.7%
2018 - 2025
Equity
€453,300▲ 15.3%
2018 - 2025
Staff (FTE)
1.2▼ 14.3%
2018 - 2025
Financials · fiscal year 2025, abbreviated schema
Trend over the years
Trend over the years
In euros
In per cent
Ratio
In full-time equivalents (FTE)
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
In full-time equivalents (FTE)
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€89,632▲ 83.9%€113,155▲ 26.2%€93,429▼ 17.4%€102,344▲ 9.5%€88,043▼ 14.0%
Net result€60,500within the sector's middle half▲ 56.3%€69,195within the sector's middle half▲ 14.4%€60,036within the sector's middle half▼ 13.2%€65,000within the sector's middle half▲ 8.3%€60,000within the sector's middle half▼ 7.7%
Equity€199,070within the sector's middle half▲ 43.7%€268,265within the sector's middle half▲ 34.8%€328,300within the sector's middle half▲ 22.4%€393,300within the sector's middle half▲ 19.8%€453,300within the sector's middle half▲ 15.3%
Total assets€692,919within the sector's middle half▲ 20.7%€779,373within the sector's middle half▲ 12.5%€599,124within the sector's middle half▼ 23.1%€684,404within the sector's middle half▲ 14.2%€701,341within the sector's middle half▲ 2.5%
Debt€486,732▲ 13.5%€508,879▲ 4.5%€262,303▼ 48.5%€282,351▲ 7.6%€239,017▼ 15.3%
Working capital€562,101above the sector's middle half▲ 14.3%€649,347above the sector's middle half▲ 15.5%€527,512above the sector's middle half▼ 18.8%€580,569above the sector's middle half▲ 10.1%€617,407above the sector's middle half▲ 6.3%
Solvency28.7%within the sector's middle half▲ 4.6pp34.4%within the sector's middle half▲ 5.7pp54.8%within the sector's middle half▲ 20.4pp57.5%within the sector's middle half▲ 2.7pp64.6%above the sector's middle half▲ 7.2pp
Current ratio7.58above the sector's middle half▼ 9.757.54above the sector's middle half▼ 0.0411.82above the sector's middle half▲ 4.289.04above the sector's middle half▼ 2.7811.64above the sector's middle half▲ 2.61
Return on assets (ROA)8.7%within the sector's middle half▲ 2.0pp8.9%within the sector's middle half▲ 0.1pp10.0%within the sector's middle half▲ 1.1pp9.5%within the sector's middle half▼ 0.5pp8.6%within the sector's middle half▼ 0.9pp
Staff (FTE)2within the sector's middle half▲ 25.0%1.1below the sector's middle half▼ 45.0%1.1below the sector's middle half=1.4within the sector's middle half▲ 27.3%1.2below the sector's middle half▼ 14.3%
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result and balance sheet
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 14% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €701,341
Fixed assets
€25,932 ▼ 18.0%
Current assets
€675,409 ▲ 3.5%
Equity and liabilities €701,341
Equity
€453,300 ▲ 15.3%
Provisions
€9,023 ▲ 3.1%
Debt
€239,017 ▼ 15.3%
Debt's share of the balance-sheet total falls from 41.3% to 34.1%. Equity is higher and debt is lower.
Key figures and ratios
Key figures and ratios
EBITDA
€96,326▼
2024 · €109,502
Cash flow
€68,282▼
2024 · €72,158
Quick ratio
7.85▲
2024 · 6.01
Debt to equity
0.53▼
2024 · 0.72
ROE
13.2%▼
2024 · 16.5%
Interest coverage
13.55▲
2024 · 10.63
Debt ≤ 1 year
€58,002▼
2024 · €72,221
Debt > 1 year
€181,016▼
2024 · €210,130
Income taxes
€24,632▼
2024 · €27,955
Staff costs
€87,685▲
2024 · €85,635
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 34,696 companies that looked in July 2024 the way this one looks now, 0.7% went bankrupt within 24 months and 95% are still going.
- Micro
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.7%
went bankrupt
3.9%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 34,696 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Filed annual accounts
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €62,204 | €72,378 | €72,362 | €85,635 | €87,685 | ▲ 2.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €12,208 | €12,960 | €9,092 | €7,158 | €8,282 | ▲ 15.7% |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | €265 | -€4,887 | €6,291 | €232 | €270 | ▲ 16.5% |
| Other operating charges640/8 | €695 | €669 | €1,972 | €728 | €1,662 | ▲ 128% |
| Gross operating margin9900 | €165,004 | €194,276 | €183,147 | €196,098 | €185,943 | ▼ 5.2% |
| Operating profit (loss)9901 | €89,632 | €113,155 | €93,429 | €102,344 | €88,043 | ▼ 14.0% |
| Financial income75/76B | €1,201 | €997 | €1,056 | €907 | €3,698 | ▲ 308% |
| Recurring financial income75 | €1,201 | €997 | €1,056 | €907 | €3,698 | ▲ 308% |
| Financial charges65/66B | €6,301 | €16,387 | €10,295 | €10,297 | €7,109 | ▼ 31.0% |
| Recurring financial charges65 | €6,301 | €10,387 | €10,295 | €10,297 | €7,109 | ▼ 31.0% |
| Non-recurring financial charges66B | - | €6,000 | - | - | - | - |
| Profit (loss) for the period before taxes9903 | €84,532 | €97,766 | €84,190 | €92,955 | €84,632 | ▼ 9.0% |
| Income taxes67/77 | €24,032 | €28,571 | €24,155 | €27,955 | €24,632 | ▼ 11.9% |
| Profit (loss) for the period9904 | €60,500 | €69,195 | €60,036 | €65,000 | €60,000 | ▼ 7.7% |
| Profit (loss) for the period to be appropriated9905 | €60,500 | €69,195 | €60,036 | €65,000 | €60,000 | ▼ 7.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €692,919 | €779,373 | €599,124 | €684,404 | €701,341 | ▲ 2.5% |
| Fixed assets21/28 | €45,402 | €30,754 | €22,853 | €31,615 | €25,932 | ▼ 18.0% |
| Tangible fixed assets22/27 | €39,402 | €30,754 | €22,853 | €31,615 | €25,932 | ▼ 18.0% |
| Plant, machinery and equipment23 | €26,949 | €26,751 | €17,496 | €22,965 | €17,436 | ▼ 24.1% |
| Furniture and vehicles24 | €12,453 | €4,003 | €5,357 | €8,650 | €8,496 | ▼ 1.8% |
| Financial fixed assets28 | €6,000 | €0 | - | - | - | - |
| Current assets29/58 | €647,517 | €748,619 | €576,272 | €652,789 | €675,409 | ▲ 3.5% |
| Stocks and contracts in progress3 | €185,572 | €191,259 | €207,553 | €219,011 | €220,337 | ▲ 0.6% |
| Stocks30/36 | €185,572 | €191,259 | €207,553 | €219,011 | €220,337 | ▲ 0.6% |
| Amounts receivable within one year40/41 | €64,679 | €112,824 | €70,852 | €82,849 | €92,145 | ▲ 11.2% |
| Trade receivables40 | €61,431 | €112,824 | €70,852 | €82,534 | €91,056 | ▲ 10.3% |
| Other amounts receivable41 | €3,248 | - | - | €315 | €1,089 | ▲ 246% |
| Current investments50/53 | €107,421 | €107,421 | €107,421 | €109,893 | €112,270 | ▲ 2.2% |
| Cash at bank and in hand54/58 | €278,596 | €326,754 | €178,667 | €229,610 | €239,479 | ▲ 4.3% |
| Deferred charges and accrued income490/1 | €11,249 | €10,361 | €11,778 | €11,427 | €11,178 | ▼ 2.2% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €692,919 | €779,373 | €599,124 | €684,404 | €701,341 | ▲ 2.5% |
| Equity10/15 | €199,070 | €268,265 | €328,300 | €393,300 | €453,300 | ▲ 15.3% |
| Contributions10/11 | €6,200 | €6,200 | €6,200 | €6,200 | €6,200 | = |
| Reserves13 | €192,870 | €262,065 | €322,100 | €387,100 | €447,100 | ▲ 15.5% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Reserves not available under the articles1311 | €1,860 | €1,860 | €1,860 | €1,860 | €1,860 | = |
| Distributable reserves133 | €191,010 | €260,205 | €320,240 | €385,240 | €445,240 | ▲ 15.6% |
| Provisions and deferred taxes16 | €7,117 | €2,230 | €8,521 | €8,753 | €9,023 | ▲ 3.1% |
| Provisions for liabilities and charges160/5 | €7,117 | €2,230 | €8,521 | €8,753 | €9,023 | ▲ 3.1% |
| Other liabilities and charges164/5 | €7,117 | €2,230 | €8,521 | €8,753 | €9,023 | ▲ 3.1% |
| Amounts payable17/49 | €486,732 | €508,879 | €262,303 | €282,351 | €239,017 | ▼ 15.3% |
| Amounts payable after more than one year17 | €401,316 | €409,606 | €213,543 | €210,130 | €181,016 | ▼ 13.9% |
| Financial debts170/4 | €401,316 | €409,606 | €213,543 | €210,130 | €181,016 | ▼ 13.9% |
| Amounts payable within one year42/48 | €85,417 | €99,273 | €48,760 | €72,221 | €58,002 | ▼ 19.7% |
| Trade debts44 | €61,558 | €67,151 | €19,512 | €57,390 | €42,555 | ▼ 25.8% |
| Suppliers440/4 | €61,558 | €67,151 | €19,512 | €57,390 | €42,555 | ▼ 25.8% |
| Taxes, remuneration and social security45 | €23,859 | €32,122 | €29,248 | €14,831 | €15,447 | ▲ 4.2% |
| Taxes450/3 | €23,859 | €32,122 | €19,838 | €6,812 | €7,053 | ▲ 3.5% |
| Remuneration and social security454/9 | - | - | €9,410 | €8,019 | €8,394 | ▲ 4.7% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €60,500 | €69,195 | €60,036 | €65,000 | €60,000 | ▼ 7.7% |
| + Depreciation and write-downs630 | €12,208 | €12,960 | €9,092 | €7,158 | €8,282 | ▲ 15.7% |
| Operating cash flow (approximation) | €72,708 | €82,156 | €69,128 | €72,158 | €68,282 | ▼ 5.4% |
| Investment in fixed assets (approximation) | - | €1,688 | -€1,191 | -€15,920 | -€2,599 | ▲ 83.7% |
| Change in cash | - | €48,158 | -€148,087 | €50,943 | €9,869 | ▼ 80.6% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Comparable companies
Similar companies · same sector, comparable size
ALPHAR
BE 0426.424.371
Schaarbeek · Eq €453,289
PHARMACIE DE LA SALM
BE 0449.069.121
Vielsalm · Eq €453,184
PHARMACIE SCHNEIDER - DEPOUHON
BE 0439.400.397
Frameries · Eq €453,718
PHARMACIE FIORE
BE 0413.622.351
Verviers · Eq €452,803
JONCKHEERE-SOMERS
BE 0648.971.273
Jette · Eq €453,842
Of 5,225 companies in this sector we hold annual accounts for 3,862. 3,397 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Timeline
17 eventsLatest 25-09-2026Next filing 31-07-2027
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
25-09
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 56 days late
2025
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 12 days late
2024
17-09
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 48 days late
2023
15-11
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 107 days late
2022
31-12
Financial
Highest result since 2018net €69,195 ▲14.4%
Operating result €113,155, net result €69,195, both a record.
31-12
Financial
Equity above €200,000Eq €268,265 ▲34.8%
3 profitable years in a row build equity to €268,265.
25-11
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 117 days late
2021
31-12
Financial
Equity above €150,000Eq €199,070 ▲43.7%
2 profitable years in a row build equity to €199,070.
20-12
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 142 days late
2020
31-12
Financial
Back to profitnet €38,699
Net result €38,699 after one loss-making year.
31-12
Financial
Liquidity triplescurrent ratio 17.33
Current ratio from 6.22 to 17.33; short-term debt falls from €81,552 to €30,118.
31-12
Financial
Equity above €100,000Eq €138,569 ▲38.7%
Equity rises from €99,870 to €138,569.
Show earlier events
22-11
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 114 days late
2019
31-12
Financial
Weakest financial yearnet -€22,836
Net result drops to -€22,836, the lowest in the series; recovery starts the following year.
09-10
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 70 days late
2018
25-09
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 56 days late
2017
29-09
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema · 60 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Support & recognitions
1 funding sourceFlanders €501 register with a recognitionFASFC 1 site
Flemish government
€50
awarded · 2022
FASFC
1
authorised site
Subsidies and aid
Flemish government
2022 · 1 entry · €50 awarded · €50 paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | €50 | €50 |
Recognitions · licences · registrations
Food safety, FASFC
1 siteMerelbeke-Melleunit no. 2.193.064.783
Company details
Private limited company · founded 29-06-2010Year ends 31-12Peppol reachable1 site
Register details
Identification
Legal formPrivate limited company
Founded29-06-2010
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0827027443
Also
9925:BE0827027443
Registered
10-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.
Sites & property
Location & real-estate footprint
Registered office, Merelbeke-Melle · 1 establishment unit since 2010
Ground area
1,124 m²
Building footprint
477 m²
Volume, LiDAR
3,090 m³
Parcel 44412B0256/00S000, Flanders · tallest building 13.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
MEPHARMA
since 2010unit no. 2.193.064.783
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44412B0256/00S000 | Flanders | 1,124 m² | 1 · 477 m² | 13.0 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Subsidies How does this company compare with its sector?Sector benchmark
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.